Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

P Lewis White(Public Health Wales), Volker Rickerts(Robert Koch Institute), Rosemary A. Barnes(Innsbruck Medical University), Tom W. Patterson, Frédéric Lamoth(Czech Academy of Sciences, Institute of Microbiology), Martina Lengerová(Central European Institute of Technology), Werner Heinz(Universitätsklinikum Würzburg), Neil T. Clancy, Sharon Chen(Westmead Hospital), Laurence Millon(Centre National de la Recherche Scientifique), Carlo Mengoli(University of Padua), Deborah Lockhart(University of Dundee), Marı́a Serna, Rasmus Krøger Hare(Statens Serum Institut), Elizabeth A. Johnson, Lena Klingspor(Karolinska University Hospital), Riina Rautemaa‐Richardson(Manchester Academic Health Science Centre), Angie Caliendo, Melinda Paholcsek(University of Debrecen), Lilyann Novak Frazer(Manchester Academic Health Science Centre), Mario Cruciani, Stéphane Bretagne(Assistance Publique – Hôpitaux de Paris), Michaela Lackner(Innsbruck Medical University), Brendan Crowley(St. James's Hospital), Alexandre Alanio(Institut Pasteur), J. Peter Donnelly(Baylor College of Medicine), Katrien Lagrou(KU Leuven), Petr Hamal(Palacký University Olomouc), Ferry Hagen(University Medical Center Utrecht), Catriona Halliday, Johan Maertens(Unknown), Wilfried Posch(Innsbruck Medical University), Rebecca Gorton, Dieter Buchheidt, Ralf Bialek, Massimo Cogliati(University of Milan), Brian Jones(University of Glasgow), Minh Hong Nguyen, Catherine Cordonnier, Malcolm Guiver, Juergen Loeffler(Augenklinik Universitätsklinikum Würzburg), Willem J. G. Melchers(Radboud University Nijmegen)
Journal of Antimicrobial Chemotherapy
August 8, 2018
Cited by 4


Related Papers